Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dementia, Vascular: later-stage trial registry
3 of 12 indexed Dementia, Vascular trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 3 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Dementia, Vascular: 12 US clinical trials tracked, 3 recruiting.
Dementia, Vascular is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 2 of these trials.
Enrollment posture brief
Registry condition dementia-vascular
OPEN 3 | RECR 25% | LATE 2 | EARLY 0 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Dementia, Vascular lists 3 open slots (25% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dementia, Vascular on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dementia, Vascular is recruiting below its size-band peers.
3 of 12 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Dementia, Vascular research.
Massachusetts General Hospital accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Dementia, Vascular enrolment sits around 250 participants.
Median target enrolment is 250 among the 11 trials that report a genuine target (sentinel values excluded). 2 of those (18.2%) plan for fewer than 100 participants.
-
Dementia, Vascular splits between interventional and observational designs.
8 interventional and 4 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
Massachusetts General Hospital
NCT04916210
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
University of Washington
NCT05596760
Home Tele Rehabilitation Therapy for Vascular Dementia
The Methodist Hospital Research Institute
NCT06289569
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
University of Michigan
NCT03403257
BRINK (BRain In Kidney Disease) Memory Study 2.0
Anne Murray
NCT04975464
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
Rush University Medical Center
NCT04337255
Rural Dementia Caregiver Project
University of California, San Francisco
NCT04428112
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
University of Oregon
NCT06471660
LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers
Hopeful Aging
NCT05516342
Zolpidem CR and Hospitalized Patients With Dementia
Massachusetts General Hospital
NCT00814502
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
VA Office of Research and Development
NCT00385684
Serotonergic Pharmacotherapy for Agitation of Dementia
Bruce Pollock
NCT00009204
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dementia, Vascular records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dementia, Vascular trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dementia, Vascular page
12 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Dementia, Vascular trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Dementia, Vascular trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia, Vascular condition card totals 12 registered trials; most-linked intervention placebo with hydrocodone/APAP PRN; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.